The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome (ACS) who were randomly assigned to receive dual antiplatelet therapy ...
Mar 12, 2018
0
3
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention (PCI), a procedure to clear blocked arteries, ...
Mar 12, 2018
0
3
Patients with acute coronary syndrome experienced a substantially lower rate of heart attack, stroke, death from cardiovascular causes and major bleeding at 12 months if genetic information was used to inform the selection ...
Mar 12, 2018
0
4
Young heart attack patients are twice as likely to die if they are admitted to hospital during the weekend compared to a weekday, according to an Italian study in more than 80,000 patients presented today at Acute Cardiovascular ...
Mar 4, 2018
0
5
Several studies being presented at the American College of Cardiology's 67th Annual Scientific Session demonstrate how the computer science technique known as machine learning can be used to accurately predict clinical outcomes ...
Feb 28, 2018
0
2
(HealthDay)—For patients with acute coronary syndrome (ACS), treatment with direct oral anticoagulants (DOACs) in addition to antiplatelet therapy (APT) appears efficacious for those with ST-segment elevation myocardial ...
Feb 9, 2018
0
3
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
Feb 8, 2018
0
8
A multidisciplinary approach aimed at providing emergency physicians with a foundation of knowledge regarding ischemic stroke in young women and addressing the unique challenges in the evaluation and diagnosis of ischemic ...
Dec 27, 2017
0
14
(HealthDay)—Switching dual antiplatelet therapy (DAPT) from aspirin plus ticagrelor or prasugrel to aspirin plus clopidogrel after acute coronary syndrome (ACS) provides benefits regardless of initial platelet reactivity, ...
Dec 20, 2017
0
4
(HealthDay)—High-sensitivity troponin (hsTnT) assay can identify patients presenting with suspected acute coronary syndrome at very low risk for 30-day adverse cardiac events (ACE), according to a study published online ...
Dec 14, 2017
0
4
